Application 211669
- Type
- ANDA
- Sponsor
- MEITHEAL
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CISATRACURIUM BESYLATE | CISATRACURIUM BESYLATE | INJECTABLE;INJECTION | EQ 2MG BASE/ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 71288-714 | Cisatracurium Besylate | Cisatracurium Besylate | Meitheal Pharmaceuticals Inc. | ANDA | Current |
| 71288-714 | Cisatracurium Besylate | Cisatracurium Besylate | Meitheal Pharmaceuticals Inc. | ANDA | Current |
| 71288-714 | Cisatracurium Besylate | Cisatracurium Besylate | Meitheal Pharmaceuticals Inc. | ANDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 58462 | ORIG | 2019-04-29 |